Sequencing

Test 100% of your genes. Lifelong health intelligence.

Employees
11–50
Business Model
B2C
Last Round
SeedNov 2022
Rounds
1

About

Sequencing.com is a direct-to-consumer DNA interpretation company that provides whole genome sequencing kits and a marketplace of DNA analysis apps and reports. The platform analyzes genetic data from any DNA test including 23andMe and AncestryDNA, delivering personalized health, medication, nutrition, and ancestry insights. Sequencing.com is HIPAA-compliant and offers continuous reanalysis as genomic research advances.

Summary

Sequencing is a company based in Los Angeles, United States. Its most recent funding was a Seed round in Nov 2022. Investors include Lerer Hippeau, Red Sea Ventures and Global Founders Capital.

Tech & App Stack

2 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors